MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 275 filers reported holding MYRIAD GENETICS INC in Q4 2013. The put-call ratio across all filers is 4.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $941 | +204.5% | 58,688 | +339.7% | 0.01% | +450.0% |
Q2 2023 | $309 | +2.7% | 13,348 | +3.1% | 0.00% | -33.3% |
Q1 2023 | $301 | +6.4% | 12,951 | -33.5% | 0.00% | 0.0% |
Q4 2022 | $283 | -100.0% | 19,477 | -35.0% | 0.00% | -57.1% |
Q3 2022 | $572,000 | -40.6% | 29,966 | -43.4% | 0.01% | -30.0% |
Q2 2022 | $963,000 | -1.8% | 52,989 | +36.1% | 0.01% | +42.9% |
Q1 2022 | $981,000 | -49.6% | 38,939 | -44.8% | 0.01% | -36.4% |
Q4 2021 | $1,947,000 | +12.8% | 70,550 | +32.0% | 0.01% | +37.5% |
Q3 2021 | $1,726,000 | +933.5% | 53,445 | +881.4% | 0.01% | +700.0% |
Q2 2021 | $167,000 | -89.4% | 5,446 | -89.5% | 0.00% | -87.5% |
Q1 2021 | $1,576,000 | +109.6% | 51,743 | +36.0% | 0.01% | +100.0% |
Q4 2020 | $752,000 | +26.2% | 38,052 | -16.8% | 0.00% | 0.0% |
Q3 2020 | $596,000 | +199.5% | 45,713 | +159.9% | 0.00% | +100.0% |
Q2 2020 | $199,000 | -32.8% | 17,588 | -15.0% | 0.00% | -33.3% |
Q1 2020 | $296,000 | -47.9% | 20,683 | -0.9% | 0.00% | -40.0% |
Q4 2019 | $568,000 | +49.1% | 20,861 | +56.9% | 0.01% | +66.7% |
Q3 2019 | $381,000 | -19.8% | 13,292 | -22.2% | 0.00% | 0.0% |
Q2 2019 | $475,000 | -1.2% | 17,085 | +18.0% | 0.00% | -25.0% |
Q1 2019 | $481,000 | -81.5% | 14,478 | -83.8% | 0.00% | -82.6% |
Q4 2018 | $2,598,000 | +615.7% | 89,370 | +821.0% | 0.02% | +666.7% |
Q2 2018 | $363,000 | -30.9% | 9,704 | -45.4% | 0.00% | -25.0% |
Q1 2018 | $525,000 | +129.3% | 17,779 | +166.4% | 0.00% | +100.0% |
Q4 2017 | $229,000 | +34.7% | 6,673 | +42.2% | 0.00% | +100.0% |
Q3 2017 | $170,000 | +68.3% | 4,694 | +19.8% | 0.00% | 0.0% |
Q2 2017 | $101,000 | -66.3% | 3,917 | -78.2% | 0.00% | -66.7% |
Q4 2016 | $300,000 | -26.5% | 17,968 | -9.4% | 0.00% | -25.0% |
Q3 2016 | $408,000 | +240.0% | 19,835 | +407.5% | 0.00% | +300.0% |
Q2 2016 | $120,000 | -59.0% | 3,908 | -50.0% | 0.00% | -50.0% |
Q1 2016 | $293,000 | +71.3% | 7,822 | +97.2% | 0.00% | +100.0% |
Q4 2015 | $171,000 | -35.5% | 3,967 | -44.0% | 0.00% | -50.0% |
Q3 2015 | $265,000 | -15.1% | 7,080 | -22.8% | 0.00% | 0.0% |
Q2 2015 | $312,000 | +110.8% | 9,168 | +119.5% | 0.00% | +100.0% |
Q1 2015 | $148,000 | -72.4% | 4,176 | -73.5% | 0.00% | -66.7% |
Q4 2014 | $537,000 | -28.1% | 15,761 | -18.6% | 0.00% | -25.0% |
Q3 2014 | $747,000 | +445.3% | 19,366 | +451.4% | 0.00% | +300.0% |
Q2 2014 | $137,000 | +3.0% | 3,512 | -10.0% | 0.00% | 0.0% |
Q1 2014 | $133,000 | -85.4% | 3,901 | -91.0% | 0.00% | -75.0% |
Q4 2013 | $911,000 | +167.2% | 43,437 | +199.2% | 0.00% | +300.0% |
Q3 2013 | $341,000 | – | 14,517 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |